Breakthrough Therapy Uses Virus to Combat Brain Cancer
Science Daily
A groundbreaking therapy using an engineered virus shows promise in enhancing immune response against glioblastoma, potentially revolutionizing treatment for this aggressive cancer.
Oncolytic virus therapy shows promise for glioblastoma treatment.
Engineered herpes virus targets cancer cells while sparing healthy tissue.
Increased immune T cell presence linked to longer patient survival.
Findings could transform 20-year standard care for glioblastoma.